WO2008139879A1 - G蛋白質共役型レセプター抑制剤および医薬 - Google Patents
G蛋白質共役型レセプター抑制剤および医薬 Download PDFInfo
- Publication number
- WO2008139879A1 WO2008139879A1 PCT/JP2008/057917 JP2008057917W WO2008139879A1 WO 2008139879 A1 WO2008139879 A1 WO 2008139879A1 JP 2008057917 W JP2008057917 W JP 2008057917W WO 2008139879 A1 WO2008139879 A1 WO 2008139879A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- coupled receptor
- pharmaceutical product
- receptor inhibitor
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009514078A JPWO2008139879A1 (ja) | 2007-04-26 | 2008-04-24 | G蛋白質共役型レセプター抑制剤および医薬 |
EP08752016A EP2154131A4 (en) | 2007-04-26 | 2008-04-24 | INHIBITOR OF THE G-PROTEIN-COUPLED RECEPTOR AND PHARMACEUTICAL PRODUCT |
US12/597,570 US20100274022A1 (en) | 2007-04-26 | 2008-04-24 | G protein-coupled receptor inhibitor and pharmaceutical product |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007117458 | 2007-04-26 | ||
JP2007-117458 | 2007-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008139879A1 true WO2008139879A1 (ja) | 2008-11-20 |
Family
ID=40002095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/057917 WO2008139879A1 (ja) | 2007-04-26 | 2008-04-24 | G蛋白質共役型レセプター抑制剤および医薬 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20100274022A1 (ja) |
EP (1) | EP2154131A4 (ja) |
JP (1) | JPWO2008139879A1 (ja) |
WO (1) | WO2008139879A1 (ja) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010104195A1 (en) * | 2009-03-11 | 2010-09-16 | Banyu Pharmaceutical Co.,Ltd. | Novel isoindolin-1-one derivative |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011161030A1 (de) | 2010-06-21 | 2011-12-29 | Sanofi | Heterocyclisch substituierte methoxyphenylderivate mit oxogruppe, verfahren zu ihrer herstellung und ihre verwendung als gpr40 rezeptor modulatoren |
WO2012004270A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | Spirocyclisch substituierte 1,3-propandioxidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012004269A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | ( 2 -aryloxy -acetylamino) - phenyl - propionsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012010413A1 (de) | 2010-07-05 | 2012-01-26 | Sanofi | Aryloxy-alkylen-substituierte hydroxy-phenyl-hexinsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2014069963A1 (en) | 2012-11-05 | 2014-05-08 | Lg Life Sciences Ltd. | Thioaryl derivatives as gpr120 agonists |
JP2016527280A (ja) * | 2013-08-09 | 2016-09-08 | ファンダサウン オズワルド クルス | ジフェニルオキシアルキルアミン誘導体およびアリールオキシアルキルアミン誘導体、薬学的組成物、慢性肺炎症性疾患を治療、予防、または阻止するための前記薬学的組成物の使用、ならびにそのような疾患を治療または予防するための方法 |
US10221138B2 (en) | 2013-06-27 | 2019-03-05 | Lg Chem, Ltd. | Biaryl derivatives as GPR120 agonists |
JPWO2021241659A1 (ja) * | 2020-05-29 | 2021-12-02 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5400878B2 (ja) * | 2008-06-24 | 2014-01-29 | アイアールエム・リミテッド・ライアビリティ・カンパニー | Gタンパク質共役受容体を調節するための化合物および方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996004260A1 (en) * | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes |
JP2000507216A (ja) * | 1996-02-28 | 2000-06-13 | グラクソ、グループ、リミテッド | PPAR―γに対するアゴニスト活性を有する置換4―ヒドロキシフェニルアルカン酸誘導体 |
WO2003070686A1 (fr) * | 2002-02-21 | 2003-08-28 | Asahi Kasei Pharma Corporation | Derive de l'acide phenylalcanoyle substitue et son utilisation |
JP2005015358A (ja) | 2003-06-25 | 2005-01-20 | Pharma Design Inc | 摂食障害の治療に供される医薬組成物 |
WO2005051373A1 (ja) * | 2003-11-26 | 2005-06-09 | Takeda Pharmaceutical Company Limited | 受容体機能調節剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989003819A1 (en) * | 1987-10-20 | 1989-05-05 | Otsuka Pharmaceutical Co., Ltd. | Phenylcarboxylic acid derivatives |
AU3959193A (en) * | 1992-04-10 | 1993-11-18 | Smithkline Beecham Plc | Heterocyclic compounds and their use in the treatment of type II-diabetes |
SK695A3 (en) * | 1992-07-03 | 1995-07-11 | Smithkline Beecham Plc | Heterocyclic compounds method of their production and using |
GB9311644D0 (en) * | 1993-06-05 | 1993-07-21 | Smithkline Beecham Plc | Novel compounds |
GB9315148D0 (en) * | 1993-07-22 | 1993-09-08 | Smithkline Beecham Plc | Novel compounds |
JP2002527503A (ja) * | 1998-10-21 | 2002-08-27 | ノボ ノルディスク アクティーゼルスカブ | 新規化合物類、それらの調製及び使用 |
-
2008
- 2008-04-24 JP JP2009514078A patent/JPWO2008139879A1/ja active Pending
- 2008-04-24 EP EP08752016A patent/EP2154131A4/en not_active Withdrawn
- 2008-04-24 WO PCT/JP2008/057917 patent/WO2008139879A1/ja active Application Filing
- 2008-04-24 US US12/597,570 patent/US20100274022A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996004260A1 (en) * | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes |
JP2000507216A (ja) * | 1996-02-28 | 2000-06-13 | グラクソ、グループ、リミテッド | PPAR―γに対するアゴニスト活性を有する置換4―ヒドロキシフェニルアルカン酸誘導体 |
WO2003070686A1 (fr) * | 2002-02-21 | 2003-08-28 | Asahi Kasei Pharma Corporation | Derive de l'acide phenylalcanoyle substitue et son utilisation |
JP2005015358A (ja) | 2003-06-25 | 2005-01-20 | Pharma Design Inc | 摂食障害の治療に供される医薬組成物 |
WO2005051373A1 (ja) * | 2003-11-26 | 2005-06-09 | Takeda Pharmaceutical Company Limited | 受容体機能調節剤 |
Non-Patent Citations (12)
Title |
---|
AM. J. CLIN. NUTR., vol. 73, 2001, pages 1019 - 1026 |
CURR DRUG TARGET CNS NEUROL DISORD, 2002 |
DIABETOLOGY, vol. 48, no. 9, 2005, pages 1700 - 13 |
DRUG, vol. 63, no. 12, 2003, pages 1785 - 97 |
ENDOCRINOLOGY, vol. 139, no. 5, 1998, pages 2363 - 8 |
NATURE MEDICINE, vol. 11, no. 1, 2005, pages 90 - 94 |
NATURE MEDICINE, vol. 11, no. 1, January 2005 (2005-01-01), pages 90 - 94 |
NEUROSCI BIOBEHAV REV., vol. 29, no. 8, 2005, pages 1361 - 73 |
NUTRITION, vol. 17, no. 3, 2001, pages 230 - 5 |
PHYSIOL BEHAV., vol. 83, no. 4, 2004, pages 617 - 21 |
See also references of EP2154131A4 * |
USUI S. ET AL.: "Identification of novel PPERalpha ligands by the structural modification of a PPARgamma ligand", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 16, 2006, pages 3249 - 3254, XP005422618 * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010104195A1 (en) * | 2009-03-11 | 2010-09-16 | Banyu Pharmaceutical Co.,Ltd. | Novel isoindolin-1-one derivative |
JP2012520240A (ja) * | 2009-03-11 | 2012-09-06 | Msd株式会社 | 新規イソインドリン−1−オン誘導体 |
US8362052B2 (en) | 2009-03-11 | 2013-01-29 | Msd K.K. | Isoindolin-1-one derivative |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011161030A1 (de) | 2010-06-21 | 2011-12-29 | Sanofi | Heterocyclisch substituierte methoxyphenylderivate mit oxogruppe, verfahren zu ihrer herstellung und ihre verwendung als gpr40 rezeptor modulatoren |
WO2012004270A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | Spirocyclisch substituierte 1,3-propandioxidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012004269A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | ( 2 -aryloxy -acetylamino) - phenyl - propionsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012010413A1 (de) | 2010-07-05 | 2012-01-26 | Sanofi | Aryloxy-alkylen-substituierte hydroxy-phenyl-hexinsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2014069963A1 (en) | 2012-11-05 | 2014-05-08 | Lg Life Sciences Ltd. | Thioaryl derivatives as gpr120 agonists |
US9447044B2 (en) | 2012-11-05 | 2016-09-20 | Lg Life Sciences Ltd. | Thioaryl derivatives as GPR120 agonists |
US10221138B2 (en) | 2013-06-27 | 2019-03-05 | Lg Chem, Ltd. | Biaryl derivatives as GPR120 agonists |
EP3628661A1 (en) | 2013-06-27 | 2020-04-01 | Lg Chem, Ltd. | Biaryl derivatives as gpr120 agonists |
JP2016527280A (ja) * | 2013-08-09 | 2016-09-08 | ファンダサウン オズワルド クルス | ジフェニルオキシアルキルアミン誘導体およびアリールオキシアルキルアミン誘導体、薬学的組成物、慢性肺炎症性疾患を治療、予防、または阻止するための前記薬学的組成物の使用、ならびにそのような疾患を治療または予防するための方法 |
JPWO2021241659A1 (ja) * | 2020-05-29 | 2021-12-02 | ||
WO2021241659A1 (ja) * | 2020-05-29 | 2021-12-02 | 株式会社 Numt | Ffar4を高発現させた脂肪細胞及びその使用 |
JP7411180B2 (ja) | 2020-05-29 | 2024-01-11 | 株式会社Numt | Ffar4を高発現させた脂肪細胞及びその使用 |
Also Published As
Publication number | Publication date |
---|---|
EP2154131A4 (en) | 2011-09-21 |
EP2154131A1 (en) | 2010-02-17 |
JPWO2008139879A1 (ja) | 2010-07-29 |
US20100274022A1 (en) | 2010-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008139879A1 (ja) | G蛋白質共役型レセプター抑制剤および医薬 | |
NZ585460A (en) | Inhibitors of human phosphatidyl-inositol 3-kinase delta | |
WO2008083248A3 (en) | Cyclopamine analogs | |
AU2008303600A8 (en) | 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives | |
WO2008109181A3 (en) | Metalloprotease inhibitors containing a heterocyclic moiety | |
WO2008064353A3 (en) | 7,8-saturated-4,5-epoxy-morphinanium analogs | |
WO2007148185A3 (en) | Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors | |
WO2008033798A3 (en) | A pyrrolopyrazin as syk-kinase inhibitor | |
WO2008013838A3 (en) | Pyridizinone derivatives | |
UA102817C2 (ru) | Способ синтеза агомелатина | |
WO2006053255A3 (en) | Novel betulin derivatives, preparation thereof and use thereof | |
WO2009016460A3 (en) | Pyrazole compounds and their use as raf inhibitors | |
WO2007105058A8 (en) | Pyrazole compounds | |
NO20084783L (no) | Syntese av acylaminoalkenylenamider nyttige som substans P antagonister | |
WO2010105179A3 (en) | Inhibitors of beta-secretase | |
WO2007084390A3 (en) | Histone deacetylase inhibitors | |
MX2009008275A (es) | Formas polimorficas de un inhibidor macrociclico del virus de la hepatitis c. | |
WO2007029037A3 (en) | Class iia histone deacetylase (hdac) substrate | |
WO2007031933A3 (en) | Stable pharmaceutical composition comprising a pyrimidine-sulfamide | |
WO2008156094A1 (ja) | ピリダジノン誘導体及びそれらを有効成分とするpde阻害剤 | |
UA102220C2 (ru) | Способ синтеза агомелатина | |
WO2007117591A3 (en) | Total synthesis of salinosporamide a and analogs thereof | |
UA97638C2 (ru) | Способ синтеза ранелата стронция и его гидратов | |
WO2006134499A3 (en) | 2-(1h-indolylsulfanyl)-aryl amine derivatives | |
WO2005005389A3 (en) | Malonamide derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08752016 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009514078 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008752016 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12597570 Country of ref document: US |